Drug Profile
Research programme: epidermal growth factor kinase inhibitors - ImClone Systems
Alternative Names: IM 092214Latest Information Update: 26 Jul 2006
Price :
$50
*
At a glance
- Originator ImClone Systems
- Class Small molecules
- Mechanism of Action Epidermal growth factor receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 31 Dec 2005 Discontinued - Preclinical for Cancer in USA (unspecified route)
- 05 May 2005 Preclinical trials in Cancer in USA (unspecified route)